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Aim To identify systemic lupus erythematosus (SLE) pa-
tients diagnosed and treated at the outpatient clinic of our 
Division fulfilling at least four American College of Rheu-
matology  (ACR)  classification  criteria  at  the  time  of  the 
study, to determine the prevalence of each of the criteria at 
three different time points, and to compare the data with 
similar studies.
Methods  We  performed  retrospective  and  descriptive 
analysis of medical records of 162 patients fulfilling at least 
4 ACR criteria. Classification criteria were counted and the 
frequency of each criterion was identified at three different 
time points: disease onset, time of diagnosis, and the time 
when the study was conducted.
Results At diagnosis and at the time when the study was 
conducted there were 3.8 and 5.4 fulfilled classification cri-
teria, respectively. The most common criterion at the time 
of the disease onset was arthritis (52.6%); at the time of 
diagnosis it was positive antinuclear antibody (ANA) titer 
(88.0%); and at the time when the study was conducted 
it was positive ANA titer (95.7%), immunologic disorder 
(89.5%),  arthritis  (71.0%),  hematologic  disorder  (70.4%), 
malar rash (61.7%), and photosensitivity (51.9%).
Conclusion The prevalence of ACR criteria in our patients 
is similar to that in other studies, especially those involv-
ing Caucasian patients. Our results confirm the value of the 
ACR criteria in patients with an already established diagno-
sis. This is the first study on the prevalence of disease mani-
festations among Croatian patients with SLE.
Mislav Cerovec, Branimir 
Anić, Ivan Padjen, Nada 
Čikeš
Division of Clinical Immunology 
and Rheumatology, Department 
of Internal Medicine, University 
of Zagreb School of Medicine, 
University Hospital Center Zagreb, 
Zagreb, Croatia
Received: November 2, 2011
Accepted: April 10, 2012
Correspondence to:  
Mislav Cerovec 
Division of Clinical Immunology and 
Rheumatology, Department of 
Internal Medicine, 
University of Zagreb School of 
Medicine, University Hospital Centre 
Zagreb, Kišpatićeva 12 
10000 Zagreb, Croatia 
mislavc@yahoo.com
Prevalence of the American 
College of Rheumatology 
classification criteria in a 
group of 162 systemic lupus 




doi: 10.3325/cmj.2012.53.149CLINICAL SCIENCE 150 Croat Med J. 2012;53:149-54
www.cmj.hr
Systemic lupus erythematosus (SLE) is a chronic inflamma-
tory disease affecting a number of organs and organ sys-
tems (1-3). The wide spectrum of clinical features among 
patients with SLE, progress of medical research and, conse-
quently, better understanding of the disease led to a need 
for  a  unique  classification  of  disease  manifestations  for 
research purposes. The American College of Rheumatol-
ogy (ACR) developed classification criteria for SLE in 1982 
based on a study conducted on 177 patients with SLE and 
162 healthy individuals (4). The criteria have been accepted 
throughout the world, with only one revision in 1997 (3). A 
patient is considered to have SLE if at least four criteria are 
cumulatively fulfilled, with a high sensitivity and specificity 
(both 96%) in patients with an already established diagno-
sis (4). In addition to their primary role in clinical research, 
the criteria may also be used as a helpful tool for establish-
ing the diagnosis, since they comprise the majority of spe-
cific disease manifestations.
Apart from a number of case reports and case series, no 
systematically presented data are available on the preva-
lence of clinical and laboratory manifestations of the dis-
ease among Croatian patients (5-8). The aim of this study 
is 1) to identify SLE patients diagnosed and treated in the 
outpatient clinic of our Division fulfilling at least four ACR 
classification criteria at the time of the study, 2) to deter-
mine the prevalence of each of the fulfilled criteria at three 
different time points: at disease onset, the time of diagno-
sis, and the time when the study was conducted, and 3) to 
compare the data with similar studies.
PAtIeNts ANd Methods
This is a retrospective and descriptive study of the prev-
alence of the ACR criteria for classification of SLE among 
patients of the Division of Clinical Immunology and Rheu-
matology, University Hospital Centre Zagreb, diagnosed or 
suspected with SLE. We used the 1982 revised ACR clas-
sification criteria and their 1997 updated version (3,4). In 
the context of this study and everyday clinical practice, the 
term clinical diagnosis does not necessarily imply that 4 or 
more ACR criteria have been fulfilled (1-3).
Data for this study were retrieved from patient records of 
the Division’s outpatient clinic and analyzed between Sep-
tember and December 2004. At the time when the study 
was conducted, the Division kept approximately 25 000 
medical records of patients suffering from any form of 
inflammatory rheumatic disease, with at least one visit 
to the outpatient clinic in the 25-year history of the 
Division. Patients were diagnosed, treated, and followed-
up by certified rheumatologists. The Division offers gener-
al rheumatology service for the city of Zagreb and its sur-
roundings, as well as northwestern Croatia. It also serves 
as a center of excellence in connective tissue diseases, of-
fering its service to patients from the whole country, and a 
large number of patients from Bosnia and Herzegovina.
The first and second review of the medical records were 
performed by a board of the Division’s specialists working 
in pairs (a total of 6 rheumatologists). The reviewers identi-
fied medical records of 1415 patients with a clinical or sus-
pected diagnosis of SLE. These medical records were sub-
sequently evaluated.
The next inclusion criterion was patients’ visit to the out-
patient clinic within three years before the beginning of 
the study, as an indicator of a continuous follow-up. Pa-
tients not living in Croatia and/or non-Croatian citizens 
were excluded from the study. We formed a group of 333 
patients with a clinical diagnosis or suspicion of SLE, who 
were Croatian citizens and residents under regular follow-
up by rheumatologists of the Division. Their medical re-
cords were subsequently reanalyzed: the cumulative fre-
quency of each of the ACR criteria at the time of our study 
was determined. Patients fulfilling fewer than four criteria 
were excluded from further analysis. We finally identified 
162 patients fulfilling at least four ACR criteria at the time 
when the study was conducted. Having identified the 162 
patients, we counted the criteria that each patient fulfilled 
at three different time points: (a) at the disease onset, (b) at 
the time of diagnosis, and (c) at the time when the study 
was conducted. We determined the prevalence of each of 
the classification criteria at these time points. Despite the 
systematic approach, loss of data was observed due to the 
retrospective nature of the study and use of patients’ medi-
cal records for data retrieval. The loss of data was especially 
observed for the time of disease onset and the time of di-
agnosis.
The results were put into the context of similar data avail-
able in the relevant literature. Calculations (including per-
centages and medians) were performed using Microsoft 
Excel 2003 (Microsoft Corporation, Redmond, WA, USA).
Results
At the time when the study was conducted, 162 patients 
fulfilled at least four ACR criteria (Table 1). There were 145 
female and 17 male patients, between 19 and 81 years of 151 Cerovec et al: Characteristics of SLE in a group of Croatian patients
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age. The median age in the studied group was 47. Age 
range for men was between 22 and 74 years (median, 47) 
and age range for women was between 19 and 81 years 
(median, 47). At the time when the study was conducted 
there were 5.4 fulfilled classification criteria, compared to 
only 3.8 at the time of diagnosis.
Data on the frequency of subcriteria were insufficient for 
the following ACR criteria: serositis, hematologic and im-
munologic disorder (Table 1). In addition, due to the retro-
spective nature of the study, complete data for all patients 
in the observed group were not available at the time of 
disease onset and diagnosis. Data for the time of disease 
onset were available for only 78 out of 162 patients and 
data for the time of diagnosis were available for 125 pa-
tients (Table 1).
The most frequently observed classification criteria at dis-
ease  onset  were  mucocutaneous  manifestations  (malar 
and discoid rash, photosensitivity, oral ulcers) and arthritis. 
At the time of diagnosis, the most prevalent classification 
criterion was a positive ANA titer, although less frequently 
observed than at the time when the study was conducted. 
Criteria with the highest observed prevalence at the time 
when the study was conducted were from the group of 
impaired laboratory findings, ie, hematologic (cytopenias) 
and immunologic (antinuclear antibodies [ANA], anti-DNA 
antibodies and/or anti-Sm antibodies and/or lupus antico-
agulant, and/or anticardiolipin antibodies) disorders. The 
most frequently fulfilled clinical criteria were arthritis and 
malar rash.
dIsCussIoN
Our data on the prevalence of the ACR criteria at the time 
when the study was conducted are similar to the findings 
of other authors. In addition, the total number of patients 
involved in this study is comparable with some of the ma-
tABle 1. the prevalence of the American College of Rheumatology (ACR) classification criteria for systemic lupus erythematosus 
(sle) in 162 patients fulfilling at least 4 criteria at the time when the study was conducted (data available for 162 patients), at the 
time of establishing the diagnosis, and at disease onset (data available for 125/162 and 78/162 patients, respectively)
No (%) of patients fulfilling each criterion at:
ACR classification criteria for sle sle onset sle diagnosis time when the study was conducted
1 Malar rash 21 (26.9)   48 (38.4) 100 (61.7)
2 Discoid rash   4 (5.1)     7 (5.6)   24 (14.8)
3 Photosensitivity 18 (23.1)   43 (34.4)   84 (51.9)
4 Oral ulcers 11 (14.1)   18 (14.4)   27 (16.7)
5 Arthritis 41 (52.6)   69 (55.2) 115 (71.0)
6 Serositis 10 (12.8)   19 (15.2)   28 (17.3)
a Pleuritis   6 (7.7)   13 (10.4)   17 (10.5)
b Pericarditis   2 (2.6)     9 (7.2)   11 (6.8)
c Sub-criterion not determined   2 (2.6)     3 (2.4)     5 (3.1)
7 Renal disorder   6 (7.7)   19 (15.2)   42 (25.9)
8 Neurologic disorder   2 (2.6)     3 (2.4)     9 (5.6)
a Seizures   2 (2.6)     3 (2.4)     6 (3.7)
b Psychosis   0 (0.0)     0 (0.0)     3 (1.9)
9 Hematologic disorder 29 (37.2)   67 (53.6) 114 (70.4)
a Hemolytic anemia   3 (3.8)   11 (8.8)   14 (8.6)
b Leukopenia 18 (23.1)   43 (34.4)   75 (46.3)
c Lymphopenia   5 (6.4)   26 (20.8)   53 (32.7)
d Thrombocytopenia 13 (16.7)   19 (15.2)   26 (16.0)
e Sub-criterion not determined   0 (0.0)     1 (0.8)     5 (3.1)
10 Immunologic disorder 12 (15.4)   74 (59.2) 145 (89.5)
a Anti-DNA 10 (12.8)   68 (54.4) 136 (84.0)
b Anti-Sm NA*   NA*   NA*
c Antiphospholipid antibodies   3 (3.8)   32 (25.6)   45 (27.8) 
d Sub-criterion not determined   1 (1.3)     3 (2.4)     8 (4.9)
11 Antinuclear antibody 18 (23.1) 110 (88.0) 155 (95.7)
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jor studies on the prevalence of ACR criteria and other clin-
ical manifestations among patients diagnosed with SLE 
(Table 2) (4,9-11).
The ACR criteria for classification of SLE were developed 
on the basis of the most frequent and specific clinical 
and laboratory disease manifestations observed in 177 
patients diagnosed with SLE (4). A patient is considered 
to have SLE if at least 4 of the 11 criteria are fulfilled, seri-
ally or simultaneously, during any interval of observation 
(3,4). For patients with an already established diagnosis, 
the sensitivity and specificity of the ACR criteria are both 
very high – 96% (3). Although the criteria are widely used 
in the research setting, it is still not clear whether estab-
lishing the diagnosis of SLE should solely rely on the strict 
fulfillment of at least four criteria at such an early stage of 
the disease course.
Our results confirm the value of the criteria in patients with 
an already established diagnosis. On the other hand, they 
reveal their questionable value in the early stages of the 
disease course, including the time of diagnosis – the sensi-
tivity of the criteria may be much lower than in the patients 
with an already established diagnosis. There was an obvi-
ous difference between the prevalence of ACR criteria at 
the disease onset and at more developed stages of the dis-
ease course. This can be attributed to the retrospective na-
ture of our study and the reliance of the available data on 
the criteria at the disease onset primarily on patients’ histo-
ries. It is noteworthy that the presence of only two classifi-
cation criteria can be identified on the basis of a patient’s 
history: photosensitivity and pleuritis (3,4).
Analysis of the prevalence of fulfilled classification criteria 
at the time of diagnosis implicates that the diagnosis es-
tablished in the clinical setting does not completely de-
pend on the fulfillment of the ACR criteria. The number of 
fulfilled ACR criteria at the time of diagnosis was 3.8, reveal-
ing that a considerable percentage of patients were clini-
cally diagnosed with SLE yet not fulfilling four ACR criteria. 
A variety of different clinical and laboratory findings should 
be taken into account when establishing the diagnosis of 
SLE in everyday practice. There are symptoms and signs oc-
curring at the beginning of the disease course that do not 
fully meet the ACR criteria (ie, arthralgia without arthritis, 
oral ulcers not observed by a physician but only as a part 
of a patient’s history) (12,13). Furthermore, there is a myriad 
of clinical and laboratory parameters that are not included 
in the classification criteria but can, nevertheless, indicate 
the presence of disease or disease activity (ie, fever, various 
forms of skin eruptions or mucosal changes, different neu-
rological manifestations, complement deficiency, human 
leukocyte antigens associated with SLE) (1,2).
Cumulative fulfillment of 4 or more ACR classification cri-
teria assures that patients in an observed group are really 
suffering from SLE. However, it should be noted that the 
presence of multiple classification criteria does not neces-
sarily mean a severe course of the disease. It is not possible 
to assess SLE disease activity using the classification criteria 
– different disease activity indexes have been developed 
for this purpose (14-18).
We faced several limitations and biases in our study. The 
retrospective design led to a loss of a considerable num-
tABle 2. Comparison of the prevalence of each of the American College of Rheumatology (ACR) classification criteria between our 
study (Croatia) and similar studies conducted in patients diagnosed with systemic lupus erythematosus (sle)
Patients (%)
Criteria usA (4) europe (9) Germany (10) Norway (11) Croatia
Malar rash   57.0   2 6 . 4   67.0   51.0   61.7
Discoid rash   18.0    5 . 4   44.0   16.0   14.8
Photosensitivity   43.0   1 8 . 7   72.0   49.0   51.9
Oral ulcers   27.0    8 . 9   33.0     2.0   16.7
Arthritis   86.0   4 1 . 3   71.0   87.0   71.0
Serositis   56.0     12.9   30.0   42.0   17.3
Renal disorder   51.0   2 2 . 2   42.0   22.0   25.9
Neurologic disorder   20.0   1 3 . 6   21.0   11.0   5 . 6
Hematologic disorder   59.0     12.8   97.0   46.0   70.4
Immunologic disorder   85.0    NA*   96.0   67.0    89.5
Antinuclear antibody   99.0   9 0 . 5   96.0 100.0   95.7
Number of patients 177 1000 338   55 162
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ber of patient data on the prevalence of ACR criteria at the 
time of diagnosis and even more at the disease onset, as 
well as on the prevalence of several subcriteria. Additional-
ly, our analysis was a single-center one. Although the larg-
est number of Croatian SLE patients is followed-up by the 
Division, other institutions’ patients should have also been 
included in the study in order to obtain results more repre-
sentative for the whole country.
In conclusion, the prevalence of ACR criteria at the time 
when the study was conducted is similar to other studies, 
especially those involving Caucasian patients. This confirms 
the value of the ACR criteria in patients with an already es-
tablished diagnosis. However, it seems that the ACR criteria 
alone cannot be used as diagnostic criteria due to a variety 
of clinical and laboratory findings that should be consid-
ered when establishing the diagnosis but are not included 
in the ACR criteria. This study can serve as a promising step 
toward a more thorough research of SLE disease manifes-
tations, especially prospective follow-up.
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